[ad_1]
Farsalinos, K. E., Romagna, G., Tsiapras, D., Kyrzopoulos, S. & Voudris, V. Characteristics, perceived side effects and benefits of electronic cigarette use: a worldwide survey of more than 19,000 consumers. Int. J. Environ. Res. Public Health
11, 4356–73 (2014).
Biener, L. & Hargraves, J. L. A Longitudinal Study of Electronic Cigarette Use Among a Population-Based Sample of Adult Smokers: Association With Smoking Cessation and Motivation to Quit. Nicotine Tob. Res.
17, 127–133 (2015).
Gallus, S. et al. E-Cigarette Awareness, Use, and Harm Perceptions in Italy: A National Representative Survey. Nicotine Tob. Res.
16, 1541–1548 (2014).
Pechacek, T. F., Nayak, P., Gregory, K. R., Weaver, S. R. & Eriksen, M. P. The Potential That Electronic Nicotine Delivery Systems Can be a Disruptive Technology: Results From a National Survey. Nicotine Tob. Res.
18, 1989–1997 (2016).
Pearson, J. L., Richardson, A., Niaura, R. S., Vallone, D. M. & Abrams, D. B. e-Cigarette Awareness, Use, and Harm Perceptions in US Adults. Am. J. Public Health
102, 1758–1766 (2012).
Brose, L. S., Brown, J., Hitchman, S. C. & McNeill, A. Perceived relative harm of electronic cigarettes over time and impact on subsequent use. A survey with 1-year and 2-year follow-ups. Drug Alcohol Depend.
157, 106–11 (2015).
Wagoner, K. G. et al. E-cigarettes, Hookah Pens and Vapes: Adolescent and Young Adult Perceptions of Electronic Nicotine Delivery Systems: Table 1. Nicotine Tob. Res.
18, 2006–2012 (2016).
Patel, D. et al. Reasons for current E -cigarette use among U.S. adults. Prev. Med. (Baltim).
93, 14–20 (2016).
ASH Action on Smoking and Health. Use of electronic cigarettes (vapourisers) among adults in Great Britain | Action on Smoking and Health. May (2017). Available at: http://ash.org.uk/information-and-resources/fact-sheets/use-of-electronic-cigarettes-vapourisers-among-adults-in-great-britain/ (Accessed: 11th August 2017).
Kistler, C. et al. Consumers’ Preferences for Electronic Nicotine Delivery System Product Features: A Structured ContentAnalysis. Int. J. Environ. Res. Public Health
14, 613 (2017).
Soule, E. K., Maloney, S. F., Guy, M. C., Eissenberg, T. & Fagan, P. User identified positive outcome expectancies of electronic cigarette use: A concept mapping study. Psychol. Addict. Behav.
31, 343–353 (2017).
Farsalinos, K. E. & Polosa, R. Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review. Ther. Adv. drug Saf.
5, 67–86 (2014).
Goniewicz, M. L. et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob. Control
23, 133–9 (2014).
Margham, J. et al. Chemical Composition of Aerosol from an E-Cigarette: A Quantitative Comparison with Cigarette Smoke. Chem. Res. Toxicol.
29, 1662–1678 (2016).
Nutt, D. J. et al. Estimating the Harms of Nicotine-Containing Products Using the MCDA Approach. Eur. Addict. Res.
20, 218–225 (2014).
Mcneill, A., Ls, B., Calder, R. & Sc, H. E-cigarettes: an evidence update A report commissioned by Public Health England. (2015).
Royal College of Physicians. Nicotine without smoke: Tobacco harm reduction | RCP London. RCP London (2016). Available at: https://www.rcplondon.ac.uk/projects/outputs/nicotine-without-smoke-tobacco-harm-reduction-0 (Accessed: 11th August 2017).
Dinakar, C. & O’Connor, G. T. The Health Effects of Electronic Cigarettes. N. Engl. J. Med.
375, 1372–1381 (2016).
Polosa, R. Electronic cigarette use and harm reversal: emerging evidence in the lung. BMC Med.
13, 54 (2015).
Cibella, F. et al. Lung function and respiratory symptoms in a randomized smoking cessation trial of electronic cigarettes. Clin. Sci.
130, 1929–1937 (2016).
Campagna, D. et al. Changes in breathomics from a 1-year randomized smoking cessation trial of electronic cigarettes. Eur. J. Clin. Invest.
46, 698–706 (2016).
Polosa, R., Caponnetto, P., Cibella, F. & Le-Houezec, J. Quit and smoking reduction rates in vape shop consumers: a prospective 12-month survey. Int. J. Environ. Res. Public Health
12, 3428–38 (2015).
Centers for Disease Control and Prevention. State-Specific Secondhand Smoke Exposure and Current Cigarette Smoking Among Adults–United States, 2008. MMWR Morb Mortal Wkly Rep
58, 1232–5 (2009).
Miller, M. R. et al. Standardisation of spirometry. Eur. Respir. J.
26, 319–338 (2005).
Quanjer, P. H. et al. Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations. Eur. Respir. J.
40, 1324–1343 (2012).
American Thoracic Society & European Respiratory Society. ATS/ERS Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric Oxide and Nasal Nitric Oxide, 2005. Am. J. Respir. Crit. Care Med. 171, 912–930 (2005).
United States. Public Health Service. Office of the Surgeon General. How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease: a report of the Surgeon General. (U.S. Dept. of Health and Human Services, Public Health Service, Office of the Surgeon General, 2010).
Farsalinos, K. et al. Effect of continuous smoking reduction and abstinence on blood pressure and heart rate in smokers switching to electronic cigarettes. Intern. Emerg. Med.
11, 85–94 (2016).
Polosa, R. et al. Blood Pressure Control in Smokers with Arterial Hypertension Who Switched to Electronic Cigarettes. Int. J. Environ. Res. Public Health
13, 1123 (2016).
Department of Health, U. et al. E-Cigarette Use Among Youth and Young Adults: A Report of the Surgeon General.
Sosnowski, T. R. & Kramek-Romanowska, K. Predicted Deposition of E-Cigarette Aerosol in the Human Lungs. J. Aerosol Med. Pulm. Drug Deliv.
29, 299–309 (2016).
Mikheev, V. B., Brinkman, M. C., Granville, C. A., Gordon, S. M. & Clark, P. I. Real-Time Measurement of Electronic Cigarette Aerosol Size Distribution and Metals Content Analysis. Nicotine Tob. Res.
18, 1895–1902 (2016).
Rowell, T. R. & Tarran, R. Will chronic e-cigarette use cause lung disease? Am. J. Physiol. – Lung Cell. Mol. Physiol.
309, L1398–L1409 (2015).
Vardavas, C. I. et al. Short-term Pulmonary Effects of Using an Electronic Cigarette. Chest
141, 1400–1406 (2012).
Flouris, A. D. et al. Acute impact of active and passive electronic cigarette smoking on serum cotinine and lung function. Inhal. Toxicol.
25, 91–101 (2013).
Ferrari, M. et al. Short-term effects of a nicotine-free e-cigarette compared to a traditional cigarette in smokers and non-smokers. BMC Pulm. Med.
15, 120 (2015).
Polosa, R. et al. Persisting long term benefits of smoking abstinence and reduction in asthmatic smokers who have switched to electronic cigarettes. Discov. Med.
21, 99–108 (2016).
Polosa, R. et al. Evidence for harm reduction in COPD smokers who switch to electronic cigarettes. Respir. Res.
17, 166 (2016).
Hoffman, E. A., Simon, B. A. & McLennan, G. State of the Art. A structural and functional assessment of the lung via multidetector-row computed tomography: phenotyping chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc.
3, 519–32 (2006).
Remy-Jardin, M., Remy, J., Gosselin, B., Becette, V. & Edme, J. L. Lung parenchymal changes secondary to cigarette smoking: pathologic-CT correlations. Radiology
186, 643–651 (1993).
Dhariwal, J. et al. Smoking Cessation in COPD Causes a Transient Improvement in Spirometry and Decreases Micronodules on High-Resolution CT Imaging. Chest
145, 1006–1015 (2014).
Regan, E. A. et al. Clinical and Radiologic Disease in Smokers With Normal Spirometry. JAMA Intern. Med.
175, 1539 (2015).
Akpinar-Elci, M., Travis, W. D., Lynch, D. A. & Kreiss, K. Bronchiolitis obliterans syndrome in popcorn production plant workers. Eur. Respir. J.
24, 298–302 (2004).
van Rooy, F. G. B. G. J. et al. Bronchiolitis obliterans syndrome in chemical workers producing diacetyl for food flavorings. Am. J. Respir. Crit. Care Med.
176, 498–504 (2007).
Farsalinos, K. E., Kistler, K. A., Gillman, G. & Voudris, V. Evaluation of electronic cigarette liquids and aerosol for the presence of selected inhalation toxins. Nicotine Tob. Res.
17, 168–74 (2015).
Allen, J. G. et al. Flavoring Chemicals in E-Cigarettes: Diacetyl, 2,3-Pentanedione, and Acetoin in a Sample of 51 Products, Including Fruit-, Candy-, and Cocktail-Flavored E-Cigarettes. Environ. Health Perspect.
124, 733–9 (2015).
Etter, J.-F. Gateway effects and electronic cigarettes. Addiction. https://doi.org/10.1111/add.13924 (2017).
Farsalinos, K. E., Poulas, K., Voudris, V. & Le Houezec, J. Prevalence and correlates of current daily use of electronic cigarettes in the European Union: analysis of the 2014 Eurobarometer survey. Intern. Emerg. Med. https://doi.org/10.1007/s11739-017-1643-7 (2017).
Tashkin, D. P. et al. Comparison of Lung Function in Young Nonsmokers and Smokers Before and After Initiation of the Smoking Habit. Am. Rev. Respir. Dis.
128, 12–16 (1983).
Kohansal, R., Soriano, J. B. & Agusti, A. Investigating the natural history of lung function: facts, pitfalls, and opportunities. Chest
135, 1330–1341 (2009).
SCANLON, P. D. et al. Smoking Cessation and Lung Function in Mild-to-Moderate Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med.
161, 381–390 (2000).
Niewoehner, D. E., Kleinerman, J. & Rice, D. B. Pathologic Changes in the Peripheral Airways of Young Cigarette Smokers. N. Engl. J. Med.
291, 755–758 (1974).
Woodruff, P. G. et al. Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function. N. Engl. J. Med.
374, 1811–1821 (2016).
[ad_2]
Source link
Natrends 